TPC Tutor Perini Corporation

Rudolph & Sletten Awarded Design-Build Contract for New Precision Cancer Medicine Building at UCSF Mission Bay

Tutor Perini Corporation (NYSE: TPC), a leading civil and building construction company, announced today that its subsidiary, Rudolph and Sletten, has been awarded a design-build contract by the University of California, San Francisco (UCSF), for the construction of a new Precision Cancer Medicine Building (PCMB) at UCSF Mission Bay. The contract value is undisclosed. The project scope of work includes construction of a new six-story, 170,000-square-foot adult outpatient cancer center. The PCMB award continues Rudolph and Sletten’s successful history delivering high-quality projects on the UCSF Mission Bay campus.

This design-build project will be built by Rudolph and Sletten in a partnership with Stantec, who is providing the design services. The majority of the contract value will be included in the Company’s backlog early next year, ahead of the start of construction, which is scheduled to begin in the spring of 2017. The building is expected to open for patients in the spring of 2019.

About Tutor Perini Corporation

Tutor Perini Corporation is a leading civil and building construction company offering diversified general contracting and design-build services to private clients and public agencies throughout the world. We have provided construction services since 1894 and have established a strong reputation within our markets by executing large complex projects on time and within budget while adhering to strict quality control measures.

About Rudolph and Sletten

Rudolph and Sletten, Inc. is one of the leading general contracting firms on the West Coast and California’s premier healthcare builder. As a pacesetter in the construction industry, Rudolph and Sletten has provided quality-oriented general contracting and construction management services for five decades. Rudolph and Sletten’s expert professionals manage each job comprehensively, from site selection and preconstruction services through project completion. With its corporate headquarters in Redwood City, the company also has regional offices in Roseville, Irvine, and San Diego, California.

Rudolph and Sletten’s building expertise includes virtually all types of projects with an emphasis on those markets where their technical expertise and quality excel: biotech and pharmaceutical; healthcare; and technology. Other areas of expertise include commercial office and corporate campuses, education, gaming and hospitality, justice, government, sports and entertainment and industrial facilities. Rudolph and Sletten’s current clients include Hewlett-Packard, Genentech, Kaiser Permanente, Stanford University, the Monterey Bay Aquarium, Johnson & Johnson, Agilent Technologies, and the UC and CSU University systems.

EN
26/09/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Tutor Perini Corporation

Tutor Perini Corporation - September 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: December 6, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

Monthly Insider Special Screens: December 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Tutor Perini Corp: 1 director

A director at Tutor Perini Corp bought 40,000 shares at 64.124USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch